VildoMet
VildoMet is manufactured by HIGH-Q PHARMACEUTICAL.
http://www.high-qpharmaceutical.com
Use:
VildoMet is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus whose diabetes is not adequately controlled on metformin hydrochloride or vildagliptin alone or who are already treated with the combination of vildagliptin and metformin hydrochloride as separate tablets.
Package Contains:
14 Tablets of (50mg/850mg).
Composition:
This Drug is available for oral administration as:
- VildoMet Tablets 50mg/500mg
Each film-coated tablet contains:
- Vildagliptin MS – 50mg
- Metformin HCl USP – 500 mg
- Mfg. Specs: HIGH-Q
- VildoMet Tablets 50mg/850mg
Each film-coated tablet contains:
- Vildagliptin MS – 50mg
- Metformin HCl USP – 850 mg
- Mfg. Specs: HIGH-Q
- VildoMet Tablets 50mg/1000mg
Each film-coated tablet contains:
- Vildagliptin MS – 50mg
- Metformin HCl USP – 1000 mg
- Mfg. Specs: HIGH-Q
Dosage and Administration:
The recommended starting dose should be based on the patient’s current regimen of vildagliptin and metformin hydrochloride. This medication should be given with meals to reduce the gastrointestinal side effects associated with metformin hydrochloride.
Contra-indication:
- Hypersensitivity.
- Renal diseases.
- Congestive heart failure.
- Diabetic ketoacidosis.
- Radiologic Studies.
Severe Affects:
This medication may cause severe effects on special kinds of patients such as:
- Patient with renal impairment.
- Patient with hepatic impairment.
- Pediatric patient.
- Elderly.
Dosage:
As directed by the physician.
Instructions:
- Store below 30’C
- Protect from light and moisture.
- Keep all medicines out of the reach of the children.
- To be sold on prescription of a registered medical practitioner only.
By: Tayyaba Zareen